GLG LLC’s Cellectis CLLS Stock Holding History

GLG LLC’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-183,959	Closed	-$4.85M	–	549
2015 Q3	$4.85M	Buy	183,959 +6,324	+4%	+$212K	0.12%	175
2015 Q2	$6.41M	Buy	+177,635	New	+$6.24M	0.14%	179

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

CCP

Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GLG LLC's CLLS Position: Q4 2015 in Review

GLG LLC sold out of Cellectis (CLLS) in Q4 2015, closing a stake of 183,959 shares — an estimated $4.85M sold.

GLG LLC first reported a position in CLLS in Q2 2015 and held it in 2 quarters. The position peaked at $6.41M in Q2 2015. 48 funds tracked by Wall St. Rank hold CLLS as of Q4 2015.

GLG LLC reported no remaining Cellectis position as of Q4 2015 after selling out during the quarter.
GLG LLC sold 183,959 Cellectis shares in Q4 2015, an estimated $4.85M.
GLG LLC first reported a position in Cellectis in Q2 2015 and held it in 2 quarters.
GLG LLC's Cellectis position peaked at $6.41M in Q2 2015.
48 funds tracked by Wall St. Rank held Cellectis as of Q4 2015.

Based on GLG LLC's 13F filing for Q4 2015, filed 16 Feb 2016.